Innovotech (CVE:IOT) Stock Price Up 21.9% – Should You Buy?

Innovotech Inc. (CVE:IOTGet Free Report) rose 21.9% during trading on Wednesday . The stock traded as high as C$0.20 and last traded at C$0.20. Approximately 152,075 shares changed hands during mid-day trading, an increase of 414% from the average daily volume of 29,562 shares. The stock had previously closed at C$0.16.

Innovotech Trading Up 21.9%

The firm has a market cap of C$10.14 million, a P/E ratio of 35.56 and a beta of 2.33. The business’s 50-day moving average is C$0.23 and its two-hundred day moving average is C$0.23. The company has a current ratio of 2.63, a quick ratio of 5.81 and a debt-to-equity ratio of 12.55.

About Innovotech

(Get Free Report)

Innovotech Inc provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; MBEC Assay kit, a petri dish for biofilms, which are used for research and medical device testing of microbial biofilms; and AgreGuard, an antimicrobial for crop protection. It also provides antimicrobial contract research and antimicrobial testing; antimicrobial and anti-biofilm agents; antimicrobial and anti-biofilm materials; BEST assay testing; implanted medical devices; bacteriophage testing; and analytical services.

See Also

Receive News & Ratings for Innovotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovotech and related companies with MarketBeat.com's FREE daily email newsletter.